Lacidipine and blood pressure variability in diabetic hypertensive patients

被引:38
|
作者
Frattola, A
Parati, G
Castiglioni, P
Paleari, F
Ulian, L
Rovaris, G
Mauri, G
Di Rienzo, M
Mancia, G
机构
[1] Univ Milano Bicocca, Med Clin, Monza, Italy
[2] Osped San Gerardo, Monza, Italy
[3] Osped S Luca, Ist Sci, IRCCS, Ist Auxol Italiano, Milan, Italy
[4] IRCCS Fdn Don C Gnocchi, Ctr Bioingn, Lab Ric Cardiovascolai, Milan, Italy
关键词
blood pressure monitoring; ambulatory; calcium antagonists; hypertension; essential; diabetes mellitus; baroreflex;
D O I
10.1161/01.HYP.36.4.622
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The aim of our study was to assess the effects of lacidipine, a long-acting calcium antagonist, on 24-hour average blood pressure, blood pressure variability, and baronflex sensitivity. In 10 mildly to moderately hypertensive patients with type II diabetes mellitus (aged 18 to 65 years), 24-hour ambulatory blood pressure was continuously monitored noninvasively (Portapres device) after a 3-week pretreatment with placebo and a subsequent 4-week once daily lacidipine (4 mg) or placebo treatment (double-blind crossover design). Systolic blood pressure, diastolic blood pressure, and heart rate means were computed each hour for 24 hours (day and night) at the end of each treatment period. Similar assessments were also made for blood pressure and heart rate variability (standard deviation and variation coefficient) and for 24-hour baroreflex sensitivity, which was quantified (1) in the time domain by the slope of the spontaneous sequences characterized by progressive increases or reductions of systolic blood pi-assure and RR interval and (2) in the frequency domain by the squared ratio of RR interval and systolic blood pressure spectral power approximate to0.1 and 0.3 Hz over the 24 hours. Compared with placebo, lacidipine reduced the 24-hour, daytime, and nighttime systolic and diastolic blood pressure (P<0.05) with no significant change in heart rate. It also reduced 24-hour, daytime, and nighttime standard deviation (-19.6%, - 14.4%, and -24.0%, respectively; P<0.05) and their variation coefficient. The 24-hour average slope of all sequences (7.7+/-1.7 ms/mm Hg) seen during placebo was significantly increased by lacidipine (8.7+/-1.8 ms/mm Hg, P<0.01), with a significant increase being obtained also for the 24-hour average ct coefficient at 0.1 Hz (from 5.7+/-1.5 to 6.4+/-1.3 ms/mm Hg, P<0.01). Thus, in diabetic hypertensive patients, lacidipine reduced not only 24-hour blood pressure means but also blood pressure variability. This reduction was accompanied by an improvement of baroreflex sensitivity. Computer analysis of beat-to-beat 24-hour noninvasive blood pressure monitoring may offer valuable information about the effects of antihypertensive drugs on hemodynamic and autonomic parameters in daily life.
引用
收藏
页码:622 / 628
页数:7
相关论文
共 50 条
  • [1] COMPARISON OF THE AMBULATORY BLOOD PRESSURE VARIABILITY IN DIABETIC HYPERTENSIVE AND NON DIABETIC HYPERTENSIVE PATIENTS
    Ali, Syed Nauman
    Maaz, Muhammad
    Khan, Mubasher Ali
    Almani, Tahir Mohyud Din
    Hashmi, Kashif Ali
    [J]. PAKISTAN HEART JOURNAL, 2019, 52 (04): : 381 - 385
  • [2] Blood pressure variability and its association with echocardiographic parameters in hypertensive diabetic patients
    Daniela Massierer
    Liana Farias Leiria
    Mateus Dorneles Severo
    Priscila Dos Santos Ledur
    Alexandre Dalpiaz Becker
    Fernanda Mus Aguiar
    Eliandra Lima
    Valéria Centeno Freitas
    Beatriz D. Schaan
    Miguel Gus
    [J]. BMC Cardiovascular Disorders, 16
  • [3] Blood pressure variability and its association with echocardiographic parameters in hypertensive diabetic patients
    Massierer, Daniela
    Leiria, Liana Farias
    Severo, Mateus Dorneles
    Ledur, Priscila Dos Santos
    Becker, Alexandre Dalpiaz
    Aguiar, Fernanda Mus
    Lima, Eliandra
    Freitas, Valeria Centeno
    Schaan, Beatriz D.
    Gus, Miguel
    [J]. BMC CARDIOVASCULAR DISORDERS, 2016, 16
  • [4] Effects of guided breathing on blood pressure and heart rate variability in hypertensive diabetic patients
    Howorka, Kinga
    Pumprla, Jiri
    Tamm, Jennifer
    Schabmann, Alfred
    Klomfar, Sophie
    Kostineak, Elysee
    Howorka, Nora
    Sovova, Eliska
    [J]. AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2013, 179 (1-2): : 131 - 137
  • [6] Is there an association between blood pressure variability and target organ damage in diabetic and non-diabetic hypertensive patients?
    Carmona, J
    Amado, P
    Vasconcelos, N
    Alves, J
    Rodrigues, MC
    Nazaré, J
    [J]. JOURNAL OF HYPERTENSION, 2004, 22 : S367 - S367
  • [7] Is there an association between blood pressure variability and target organ damage in diabetic and non-diabetic hypertensive patients?
    Amado, P
    Carmona, JP
    Vasconcelos, N
    Alves, J
    Nazaré, J
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 127A - 127A
  • [8] C-reactive protein and blood pressure variability in type 2 hypertensive diabetic patients
    Schein, Andressa S. O.
    Bock, Patricia M.
    Massierer, Daniela
    Gus, Miguel
    Schaan, Beatriz D.
    [J]. BLOOD PRESSURE MONITORING, 2019, 24 (02) : 52 - 58
  • [9] The effect of blood pressure variability on the prognosis of hypertensive patients
    Taher, Ziad A.
    Khayyat, Waleed W.
    Balubaid, Marwan M.
    Tashkandi, Mohamed Y.
    Khayyat, Haifaa Akif
    Kinsara, Abdulhalim Jamal
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2019, 22 (03): : 112 - 116
  • [10] Perioperative Blood Pressure Variability in the Treated Hypertensive Patients
    Kiyohara, Kanako
    Oniki, Hideyuki
    Tsuchihashi, Takuya
    Matsumura, Kiyoshi
    [J]. CLINICAL AND EXPERIMENTAL HYPERTENSION, 2013, 35 (04) : 291 - 294